Author:
Lecomte F.,Aerts J.,Plenevaux A.,Defraiteur C.,Chapuis-Hugon F.,Rozet E.,Chiap P.,Luxen A.,Pichon V.,Hubert Ph.,Hubert C.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference30 articles.
1. Tissue distribution, autoradiography, and metabolism of 4-(2’- methoxyphenyl)-1-[2’-[N-(2’’-pyridinyl)-p- [18F]fluorobenzamido]ethyl]piperazine (p-[18F]MPPF), a new serotonin 5- HT(1A) antagonist for positron emission tomography: an in vivo study in rats;Plenevaux;J. Neurochem.,2000
2. Molecular imaging with PET;Ametamey;Chem. Rev.,2008
3. U.S. Pharmacopeia;USP 39 NF 34,2016
4. 21 CFR361.1, US Department of Health and Human Services, Food and Drug Administration, Radioactive Drug Research Committee (RDRC), April 2015.
5. Current status of positron emission tomography radiotracers for serotonin receptors in humans;Zimmer;J. Label Compd. Radiopharm.,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献